Quick Answer
AVITA Medical, Inc. reported Total Revenue of $71.61 million for fiscal year 2025.
AVITA Medical, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $71.61M +11.5% |
$64.25M +28.1% |
$50.14M +45.7% |
$34.42M +17.8% |
$29.23M +104.9% |
$14.26M +160.6% |
| Net Income | -$48.59M +21.4% |
-$61.84M -74.8% |
-$35.38M -32.7% |
-$26.66M -0.3% |
-$26.58M +36.8% |
-$42.03M -67.4% |
| Diluted EPS | -$1.74 +27.2% |
-$2.39 -70.7% |
-$1.40 -230.8% |
$1.07 -8.5% |
$1.17 -43.5% |
$2.07 +32.7% |
| Total Assets | $56.39M -29.3% |
$79.71M -28.6% |
$111.64M +13.6% |
$98.26M -21.7% |
$125.50M +52.2% |
$82.46M +219.8% |
| Cash and Equivalents | $10.24M -27.1% |
$14.05M -36.5% |
$22.12M +21.8% |
$18.16M -83.6% |
$110.75M +50.4% |
$73.64M +265.0% |
| Long-Term Debt | $0.00 -100.0% |
$42.24M +6.1% |
$39.81M | — | — | — |
| Stockholders Equity | -$16.65M -470.1% |
$4.50M -90.8% |
$49.06M -42.1% |
$84.74M -26.7% |
$115.66M +59.7% |
$72.40M +247.5% |
| R&D Expense | $20.84M +2.4% |
$20.36M -2.2% |
$20.82M +50.3% |
$13.86M -6.5% |
$14.82M +61.7% |
$9.16M +14.5% |
| Operating Income | -$42.53M +24.8% |
-$56.59M -32.7% |
-$42.66M -55.1% |
-$27.50M -3.6% |
-$26.54M +37.8% |
-$42.68M -67.2% |
| Gross Profit | $58.82M +6.6% |
$55.16M +30.2% |
$42.36M +49.3% |
$28.38M +21.9% |
$23.28M +106.2% |
$11.29M +168.6% |
| Shares Outstanding | 30.57M +16.0% |
26.35M +2.6% |
25.68M +1.9% |
25.21M +1.3% |
24.90M +16.0% |
21.47M +14.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $17.06M | -12.7% | -7.4% |
| Net Income | September 30, 2025 | -$13.19M | +18.6% | -32.9% |
| Diluted EPS | September 30, 2025 | -$0.46 | +25.8% | -21.1% |
| Total Assets | September 30, 2025 | $63.73M | -21.4% | +9.6% |
| Cash and Equivalents | September 30, 2025 | $15.42M | -17.3% | +26.2% |
| Long-Term Debt | September 30, 2025 | $0.00 | -100.0% | -100.0% |
| Stockholders Equity | September 30, 2025 | -$6.67M | -154.5% | +48.3% |
| R&D Expense | September 30, 2025 | $3.75M | -31.0% | -26.8% |
| Operating Income | September 30, 2025 | -$9.15M | +33.7% | +17.9% |
| Gross Profit | September 30, 2025 | $13.88M | -15.2% | -7.2% |
| Shares Outstanding | September 30, 2025 | 30.49M | +16.3% | +14.6% |
- AVITA Medical, Inc. reported Total Revenue of $71.61 million for fiscal year 2025.
- AVITA Medical, Inc. showed an increase of +11.5% in Total Revenue compared to the prior fiscal year.
- AVITA Medical, Inc. reported Net Income of -$48.59 million for fiscal year 2025.
- AVITA Medical, Inc. showed an increase of +21.4% in Net Income compared to the prior fiscal year.
- AVITA Medical, Inc. reported Diluted EPS of $1.74 per share (loss) for fiscal year 2025.
- AVITA Medical, Inc. showed an increase of +27.2% in Diluted EPS compared to the prior fiscal year.
- AVITA Medical, Inc. reported Total Assets of $56.39 million for fiscal year 2025.
- AVITA Medical, Inc. showed a decrease of -29.3% in Total Assets compared to the prior fiscal year.
- AVITA Medical, Inc. reported Cash and Equivalents of $10.24 million for fiscal year 2025.
- AVITA Medical, Inc. showed a decrease of -27.1% in Cash and Equivalents compared to the prior fiscal year.
- AVITA Medical, Inc. reported Long-Term Debt of $0.00 for fiscal year 2025.
- AVITA Medical, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- AVITA Medical, Inc. reported Stockholders Equity of -$16.65 million for fiscal year 2025.
- AVITA Medical, Inc. showed a decrease of -470.1% in Stockholders Equity compared to the prior fiscal year.
- AVITA Medical, Inc. reported R&D Expense of $20.84 million for fiscal year 2025.
- AVITA Medical, Inc. showed an increase of +2.4% in R&D Expense compared to the prior fiscal year.
- AVITA Medical, Inc. reported Operating Income of -$42.53 million for fiscal year 2025.
- AVITA Medical, Inc. showed an increase of +24.8% in Operating Income compared to the prior fiscal year.
- AVITA Medical, Inc. reported Gross Profit of $58.82 million for fiscal year 2025.
- AVITA Medical, Inc. showed an increase of +6.6% in Gross Profit compared to the prior fiscal year.
- AVITA Medical, Inc. reported Shares Outstanding of 30.57 million shares for fiscal year 2025.
- AVITA Medical, Inc. showed an increase of +16.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: